# Beta-blOckers discoNtinuation in Patients Presenting Heart FaIlure With REcovered Left Ventricular Ejection Fraction

Study · id `cardio:ct-nct06518694` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06518694](<https://clinicaltrials.gov/study/NCT06518694>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06518694

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1300 participants.

## Technical summary

Registry record NCT06518694. Randomized; single masking; primary purpose other. Start 2025-02-11 (actual); primary completion 2027-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose other
- Phase: Phase 3
- Enrolled: 1300 participants (planned count; ClinicalTrials.gov record NCT06518694, source copy `cardio:ctgov-nct06518694-2026-01-16`, retrieved 2026-10-26)
- Started: 2025-02-11 (actual) (ClinicalTrials.gov record NCT06518694, source copy `cardio:ctgov-nct06518694-2026-01-16`, retrieved 2026-10-26)
- Primary completion: 2027-10 (anticipated) (ClinicalTrials.gov record NCT06518694, source copy `cardio:ctgov-nct06518694-2026-01-16`, retrieved 2026-10-26)
- Completion: 2027-10 (anticipated) (ClinicalTrials.gov record NCT06518694, source copy `cardio:ctgov-nct06518694-2026-01-16`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT06518694, source copy `cardio:ctgov-nct06518694-2026-01-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06518694-2026-01-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Beta-blOckers discoNtinuation in Patients Presenting Heart FaIlure With REcovered Left Ventricular Ejection Fraction
- Acronym: BONFIRE
- Condition: Heart Failure
- Intervention (Drug): Βeta-Blockers discontinued (with tapering)
- Lead sponsor: Assistance Publique - Hôpitaux de Paris
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Assistance Publique - Hôpitaux de Paris (`cardio:org-assistance-publique-hopitaux-de-paris`)

## Provenance

Content hash: 421ee8e4dca4db295de9ab12c7b11ecfb30e065410784849e7b935fa2d5f7442
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
